Icon Wealth Partners, LLC Novo Nordisk A S Transaction History

Icon Wealth Partners, LLC

$878 Million
Q3 2023

A detailed history of Icon Wealth Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 22,233 shares of NVO stock, worth $3.18 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

22,233

Previous 6,522 240.89%

Holding current value

$3.18 Million

Previous $1.06 Million 91.56%

% of portfolio

0.23%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.43 Million - $3.13 Million	15,711 Added 240.89%	22,233 $2.02 Million
Q2 2023 Aug 03, 2023	SELL	$155.98 - $172.65 $74,558 - $82,526	-478 Reduced 6.83%	6,522 $1.06 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $59,288 - $71,294	-448 Reduced 6.02%	7,000 $1.11 Million
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $182,838 - $215,725	-1,771 Reduced 19.21%	7,448 $830,000
Q1 2022 Apr 19, 2022	SELL	$93.1 - $112.54 $1,862 - $2,250	-20 Reduced 0.22%	9,219 $1.02 Million

Q4 2021 Jan 19, 2022	BUY	$95.88 - $117.08 $5,561 - $6,790	58 Added 0.63%	9,239 $1.04 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $53,522 - $67,597	634 Added 7.42%	9,181 $881,000
Q2 2021 Jul 30, 2021	BUY	$67.66 - $84.76 $47,767 - $59,840	706 Added 9.0%	8,547 $716,000
Q1 2021 Apr 26, 2021	BUY	$67.06 - $75.82 $42,113 - $47,614	628 Added 8.71%	7,841 $529,000
Q4 2020 Feb 08, 2021	BUY	$63.89 - $73.8 $95,771 - $110,626	1,499 Added 26.23%	7,213 $504,000
Q3 2020 Oct 22, 2020	BUY	$63.69 - $70.22 $84,580 - $93,252	1,328 Added 30.28%	5,714 $396,000
Q2 2020 Jul 14, 2020	SELL	$58.54 - $67.94 $14,342 - $16,645	-245 Reduced 5.29%	4,386 $287,000
Q1 2020 Apr 17, 2020	SELL	$49.46 - $64.78 $18,844 - $24,681	-381 Reduced 7.6%	4,631 $279,000
Q4 2019 Jan 29, 2020	SELL	$49.86 - $58.26 $5,085 - $5,942	-102 Reduced 1.99%	5,012 $290,000
Q3 2019 Oct 24, 2019	SELL	$47.54 - $53.43 $665 - $748	-14 Reduced 0.27%	5,114 $264,000
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $3,743 - $4,197	-80 Reduced 1.54%	5,128 $262,000
Q1 2019 May 09, 2019	BUY	$46.36 - $52.63 $8,066 - $9,157	174 Added 3.46%	5,208 $272,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $100,817 - $114,675	-2,427 Reduced 32.53%	5,034 $232,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $208,082 - $228,018	4,450 Added 147.79%	7,461 $352,000
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $21,790 - $24,806	-492 Reduced 14.05%	3,011 $139,000
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $25,602 - $30,697	-528 Reduced 13.1%	3,503 $175,000
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $191,593 - $216,585	4,031	4,031 $216,000

Others Institutions Holding NVO

# of Institutions

1,856

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $323B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.

Account

Icon Wealth Partners, LLC Novo Nordisk A S Transaction History